Pharmacogenomics, theranostics and personalized medicine-the complexities of clinical trials: challenges in the developing world
… , patients are demanding individualized therapy, with safer … 23% in the case of patients with diabetes in phase II trials. The … and a genetically diverse Indian population, each segment …..... Read More